Evidence map›Paper›PMID 38037158›Full record

ArticleInternational journal of retina and vitreous2023

Atypical pattern of ocular toxoplasmosis: recurrent inner foveal toxoplasmic retinitis (rifter).

Guilherme Macedo Souza, Laurentino Biccas, André Maia, Claudio Silveira, Rubens Belfort

Open access · goldAbstract readLetter
In one paragraph

Article in International journal of retina and vitreous, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.6field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 2 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Guilherme Macedo SouzaDepartment of Ophthalmology and Visual Science, Federal University of Sao Paulo, Sao Paulo, SP, Brazil. gmacedo4@gmail.com.ORCID http://orcid.org/0000-0002-3045-1297
Laurentino BiccasOcular Oftalmologia, Vitoria, ES, Brazil.ORCID http://orcid.org/0000-0003-2047-3983
André MaiaDepartment of Ophthalmology and Visual Science, Federal University of Sao Paulo, Sao Paulo, SP, Brazil.
Claudio SilveiraClínica Silveira, Erechim, RS, Brazil.
Rubens BelfortDepartment of Ophthalmology and Visual Science, Federal University of Sao Paulo, Sao Paulo, SP, Brazil.ORCID http://orcid.org/0000-0002-8422-3898
Instituto da Visão · BRHospital Oftalmologico de Brasília · BRInstituto Paulista de Ensino e Pesquisa · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Failure to recognize the different possible clinical presentations of ocular toxoplasmosis may delay diagnosis and treatment, compromising visual prognosis. The aim of this paper is to describe an atypical pattern of ocular toxoplasmosis, not yet described. Five Brazilian patients, from 4 different referral centers, presented similar atypical pattern of ocular toxoplasmosis characterized by mild vitritis, foveal cavitation involving predominantly all retinal layers associated with adjacent inner retinal necrosis (a necrotizing retinitis with a persisting inner retinal tissue bridge and loss of subjacent retinal layers). The appearance of the OCT image resembling a "rift", led the authors to define this pattern as a Recurrent Inner Foveal Toxoplasmic Retinitis (RIFTER), which can be considered as a new description of an atypical pattern of toxoplasma retinochoroiditis, and clinicians should be aware of it and consider testing for toxoplasmosis in patients with similar findings.

Indexed as

Ocular toxoplasmosisPosterior UveitisToxoplasma RetinochoroiditisToxoplasmosisUveitis

Identifiers

PMID38037158
PMCPMC10691084
OpenAlexW4389206218

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.